Get ready for a seismic shift in how the UK handles mergers—one that could fundamentally alter the balance of power in corporate oversight. This week, the government is set to unveil a radical overhaul of merger probes, and it’s not just a tweak—it’s a transformation that has experts buzzing with both anticipation and concern. But here’s where it gets controversial: observers warn that these changes could significantly entrench the authority of the competition regulator’s boss, raising questions about independence and political influence.
Sky News has uncovered that the Department for Business and Trade (DBT) plans to dismantle the Competition and Markets Authority’s (CMA) long-standing panel system. Under this system, independent experts gather to assess whether corporate mergers pose serious antitrust risks. Its abolition marks a dramatic departure from the status quo. And this is the part most people miss: the CMA’s ability to scrutinize certain mergers—like those between foreign companies—may be sharply curtailed under new jurisdictional limits. This could leave some deals flying under the radar, sparking debates about market fairness.
Adding fuel to the fire, government insiders reveal that officials are considering stripping affected parties of their right to appeal merger decisions on their merits. While judicial reviews would remain an option, this change could limit avenues for redress, leaving businesses and consumers with fewer tools to challenge rulings. Meanwhile, the CMA’s broad market investigations—which currently span entire industries—will be streamlined into a single, six- to 12-month process. On the surface, this sounds efficient, but critics argue it could sacrifice depth for speed.
Here’s another twist: the CMA will establish two new board sub-committees. One will oversee Phase-2 merger investigations, while the other will supervise broader market studies. Boldly, the CMA’s chief executive, Sarah Cardell, could serve on at least one of these committees, effectively amplifying her influence over high-stakes cases. This move has already sparked accusations that it replicates the old panel system—but in a less effective and more centralized form.
To illustrate, consider ongoing cases like the merger between bread producers Hovis and Kingsmill, currently under Phase-2 scrutiny, or the CMA’s lengthy probe into the UK’s veterinary services market. These examples highlight the real-world impact of these reforms. A Whitehall source described the changes as the most significant in decades, and Business Secretary Peter Kyle may announce them at this week’s World Economic Forum in Davos, framing them as a boost to economic growth.
The government argues these reforms will accelerate decision-making and provide businesses with greater certainty. Yet, they come just a year after former CMA chairman Marcus Bokkerink was ousted by ministers, including Chancellor Rachel Reeves, as part of a broader push to deregulate and stimulate Britain’s sluggish growth. But here’s the million-dollar question: Do these changes risk politicizing merger investigations? One regulatory lawyer warns, ‘The system becomes more vulnerable to political influence, giving the CMA’s CEO and board far more discretion to be interventionist—or not.’
As the debate heats up, neither the DBT nor the CMA has commented on the planned overhaul. But one thing is clear: this isn’t just a bureaucratic reshuffle—it’s a potential game-changer for how corporate power is checked in the UK. What do you think? Are these reforms a necessary modernization, or a dangerous concentration of authority? Let us know in the comments—this is one conversation you won’t want to miss.
